论文信息 - The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes - 字舞流文

The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes

J. Encinar | J. Brunet | S. Verdura | E. Cuyás | B. Martín-Castillo | J. Bosch-Barrera | J. Menéndez | T. Alarcón | Angel G. Martín | Juan Gumuzio